Inbreeding more likely occurs in small, isolated and endangered populations, and may influence the sustainable survival of a population. As the Amur tiger Panthera tigris altaica population in China experienced a severe decline in the 1990s, the recovering population may be prone to inbreeding and its potential impacts on population health. However, the inbreeding status has not been evaluated and relationships with health remain poorly understood in wild animals. Based on the genetic samples collected from the main Amur tiger habitats in China, this study analyzed the population inbreeding level, major histocompatibility complex polymorphism, parasitic infections and gut microbial structures and functions, and then explored the influence of inbreeding on these traits. Our results indicated that more than 50% of individual relationships were in cousin or half sibs, and 22.73% of individuals had moderate or high inbreeding coefficients. There was a significant positive correlation between the inbreeding level of an individual and the Toxocara cati parasitic load. Gut microbiota community structure and function were also impacted by inbreeding intensity. In conclusion, results indicate that the Amur tiger population in China has reached a moderate level of inbreeding and that there are direct interactions between inbreeding intensity and parasitic load and gut microbiota. This study thus provides an early warning on the Amur tiger population health and should prompt the construction of national and international ecological corridors and/or the re-introduction of new individuals to relieve the evident inbreeding pressure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.